Bharglob 16.5% Injection (Human Normal Immunoglobulin)

Bharglob 16.5% Injection 1’s belongs to the class of medications called ‘immunising agents’ used to treat immunoglobulin (antibody) deficiency and certain inflammatory disorders. It is used to treat immunoglobulin deficiency in people with primary immunodeficiency’s or PID (present from birth) and secondary immunodeficiency or SID (developed in the later stages of life). Bharglob 16.5% Injection 1’s is also used to treat inflammatory disorders such as primary immune thrombocytopenia (reduced number of platelets), Guillain-Barre syndrome (short-term inflammation of the peripheral nerves causing weakness of legs and upper limbs), Kawasaki disease (inflammation of blood vessels in children), chronic inflammatory demyelinating polyneuropathy or CIDP (long-term inflammation of peripheral nerves), and multifocal motor neuropathy (progressive disease leading to weakness of arms and legs).

Bharglob 16.5% Injection 1’s contains ‘Human normal immunoglobulin’, which replaces the deficient antibodies necessary to act against infections and inflammation. It works exactly as the immunoglobulins present in the body. Immunoglobulins are an essential part of the immune system which recognises the antigens or foreign elements in the body and aids in their destruction. It also helps to reduce inflammation by improving immunity.

It would be best if you took Bharglob 16.5% Injection 1’s precisely as prescribed by your doctor. Bharglob 16.5% Injection 1’s may cause side-effects such as swelling or hardening at the injection site and headache, pain in the face, back, arms, legs, joints, or neck, fever, flu-like illness (runny nose and sore throat), blisters in the mouth, and throat, and throat tightness. These side-effects are usually mild and temporary. However, if any of the side-effects persist or get worse, inform your doctor immediately.

It is not recommended to take Bharglob 16.5% Injection 1’s if you are allergic to any of its contents, or have blood clotting disorders. Before taking Bharglob 16.5% Injection 1’s, inform your doctor if you had any vaccinations recently, or have already had this product recently. Bharglob 16.5% Injection 1’s should be used with caution in people with immunoglobulin A (IgA) deficiency (IgA is a type of antibody that protects against infections). Bharglob 16.5% Injection 1’s is probably safe when given to children, pregnant women, and breastfeeding mothers. Bharglob 16.5% Injection 1’s should be used with caution in elderly people. Bharglob 16.5% Injection 1’s may not interact with alcohol. Bharglob 16.5% Injection 1’s may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy.

Immunoglobulin deficiency and inflammatory disorders such as primary immune thrombocytopenia, Guillain-Barre syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.

Bharglob 16.5% Injection 1’s acts by replacing the deficient antibodies that are necessary to act against infections and inflammation. It works exactly as the immunoglobulins present in the body. Immunoglobulins are an important part of the immune system which recognizes the antigens or foreign elements in the body and cause their destruction. It is used to treat immunoglobulin deficiency in people with primary immunodeficiency’s or PID (present from birth) and secondary immunodeficiency or SID (developed in the later stages of life). Bharglob 16.5% Injection 1’s is also used to treat inflammatory disorders such as primary immune thrombocytopenia (reduced number of platelets), Guillain-Barre syndrome (short-term inflammation of the peripheral nerves causing weakness of legs and upper limbs), Kawasaki disease (inflammation of blood vessels in children), chronic inflammatory demyelinating polyneuropathy or CIDP (long-term inflammation of peripheral nerves), and multifocal motor neuropathy (progressive disease leading to weakness of arms and legs).

Bharglob 16.5% Injection 1’s is available in the form of injection or infusion. A trained healthcare professional will give you the Bharglob 16.5% Injection 1’s injection or infusion; so do not self-administer. Bharglob 16.5% Injection 1’s injection is given subcutaneously (under the skin), whereas infusion is given via intravenous (into the vein) route.

Store in a cool and dry place away from sunlight

• Swelling or hardening at the injection site
• Headache
• Pain in the face, back, arms, legs, joints, or neck
• Fever
• Flu-like illness (runny nose and sore throat)
• Blisters in the mouth and throat
• Throat tightness